Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma

  • Authors:
    • Zhen‑Hai Zhang
    • Ya‑Guang Wu
    • Cheng‑Kun Qin
    • Zhong‑Hou Rong
    • Zhong‑Xue Su
    • Guo‑Zhe Xian
  • View Affiliations

  • Published online on: September 10, 2014     https://doi.org/10.3892/ol.2014.2520
  • Pages: 2160-2164
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous studies have shown that the expression level of stanniocalcin 2 (STC2) is associated with tumor progression. However, to date, the association between STC2 and clinicopathological factors in hepatocellular carcinoma (HCC) has not been investigated. The clinical significance of STC2 was investigated in 30 fresh HCC samples using western blot analysis and in 240 HCC tissues using immunohistochemical analysis. The level of STC2 in cancerous tissue was higher than in the matched non‑cancerous tissues. Using immunohistochemistry, the STC2‑positive group exhibited a higher incidence of lymph node metastasis and venous invasion compared with the STC2‑negative group. Kaplan‑Meier survival analysis revealed that the positive expression of STC2 correlated with poor overall survival (OS) and disease‑free survival of HCC patients (P<0.01). STC2 expression was observed to be an independent prognostic factor for OS in HCC patients by multivariate analysis (hazard ratio, 2.39; 95% confidence interval, 1.04‑5.89; P=0.013). These data suggest that STC2 expression may be a useful indicator of poor prognosis in HCC patients.
View Figures
View References

Related Articles

Journal Cover

November-2014
Volume 8 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang ZH, Wu YG, Qin CK, Rong ZH, Su ZX and Xian GZ: Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma. Oncol Lett 8: 2160-2164, 2014
APA
Zhang, Z., Wu, Y., Qin, C., Rong, Z., Su, Z., & Xian, G. (2014). Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma. Oncology Letters, 8, 2160-2164. https://doi.org/10.3892/ol.2014.2520
MLA
Zhang, Z., Wu, Y., Qin, C., Rong, Z., Su, Z., Xian, G."Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma". Oncology Letters 8.5 (2014): 2160-2164.
Chicago
Zhang, Z., Wu, Y., Qin, C., Rong, Z., Su, Z., Xian, G."Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma". Oncology Letters 8, no. 5 (2014): 2160-2164. https://doi.org/10.3892/ol.2014.2520